Ikena to cut workforce by 53%, explore strategic options (NASDAQ:IKNA)


Company restructuring on book. Business and finance concept.

syahrir maulana

Ikena Oncology (NASDAQ:IKNA) plans to cut approximately 53% of its workforce and discontinue development of its drug candidate IK-930 as it evaluates strategic options for the company, which could include a merger or asset sale.

The Boston-based biotech company said

Source link

Leave A Reply

Your email address will not be published.